|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan; and 2Department of Molecular and Cellular Pharmacology, University of Miami, Miami, Florida
Submitted 22 February 2007 ; accepted in final form 31 May 2007
The cytosolic Ca2+/Mg2+-binding protein
-parvalbumin (
-Parv) has been shown to accelerate cardiac relaxation; however, beyond an optimal concentration range,
-Parv can also diminish contractility. Mathematical modeling suggests that increasing Parv's Mg2+ affinity may lower the effective concentration of Parv ([Parv]) to speed relaxation and, thus, limit Parv-mediated depressed contraction. Naturally occurring
/
-Parv isoforms show divergence in amino acid primary structure (57% homology) and cation-binding affinities, with
-Parv having an estimated 16% greater Mg2+ affinity and
200% greater Ca2+ affinity than
-Parv. We tested the hypothesis that, at the same or lower estimated [Parv], mechanical relaxation rate would be more significantly accelerated by
-Parv than by
-Parv. Dahl salt-sensitive (DS) rats were used as an experimental model of diastolic dysfunction. Relaxation properties were significantly slowed in adult cardiac myocytes isolated from DS rats compared with controls: time from peak contraction to 50% relaxation was 57 ± 2 vs. 49 ± 2 (SE) ms (P < 0.05), validating this model system. DS cardiac myocytes were subsequently transduced with
- or
-Parv adenoviral vectors. Upon Parv gene transfer,
-Parv caused significantly faster relaxation than
-Parv (P < 0.05), even though estimated [
-Parv] was
10% of [
-Parv]. This comparative analysis showing distinct functional outcomes raises the prospect of utilizing naturally occurring Parv variants to address disease-associated slowed cardiac relaxation.
gene transfer; mechanical relaxation
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |